Patients from across the globe choose small cell carcinoma treatment in Germany because of advanced diagnostics, innovative treatment options, and internationally recognized cancer centers.
Small cell carcinoma is an aggressive form of cancer that often originates in the lungs but can occur in other parts of the body. Patients from across the globe choose small cell carcinoma treatment in Germany because of advanced diagnostics, innovative treatment options, and internationally recognized cancer centers.
International patients from the USA, Canada, Australia, and the UK benefit from highly specialized oncology care. German healthcare centers follow internationally approved protocols and collaborate closely with the American Cancer Society, Canadian Cancer Society, Australian Cancer Society, and British Cancer Society to ensure high-quality treatment standards.
Germany has become one of the top destinations for international patients seeking advanced cancer care. Hospitals across the country provide world-class facilities, transparent pricing, and fast access to some of the best oncology specialists in Europe.
All treatments follow internationally recognized guidelines from the American Cancer Society, Canadian Cancer Society, Australian Cancer Society, and British Cancer Society. Patients also receive full details about the cost of treatment in Germany for international patients, access to the best hospitals in Germany, and assistance with obtaining a medical visa (if required) for treatment.
Many patients review patient stories about small cell carcinoma treatment in Germany before deciding. With the assistance of TIG (Treatment in Germany), international patients receive end-to-end support, including medical report reviews, appointment scheduling, treatment coordination, travel planning and and other logistic arrangements.
Small cell carcinoma innovative treatments in Germany focus on therapies that precisely target tumors, improve outcomes, and reduce side effects compared to conventional approaches. Specialized oncology centers create personalized treatment plans to maintain quality of life while improving survival rates.
The main small cell carcinoma treatment options in Germany include:
TACE Therapy (Transarterial Chemoembolization)
TACP Treatment (Transarterial Chemoperfusion)
Dendritic Cell Therapy (Immunotherapy)
These therapies are available at the top hospitals in Germany and are often combined with surgery, systemic chemotherapy, and radiotherapy for optimal results.
TACE Therapy for Small Cell Carcinoma in Germany
What is TACE Therapy?
TACE therapy in Germany is a minimally invasive interventional oncology procedure used in the treatment of small cell carcinoma. Chemotherapy drugs are delivered directly into the arteries supplying the tumor, followed by embolic particles to block blood flow. This ensures high drug concentration in the tumor while reducing systemic side effects, making TACE therapy an advanced treatment option in Germany.
How TACE Therapy Works in Germany
Imaging scans are performed to identify arteries supplying the tumor
A catheter is inserted into the targeted arteries
Chemotherapy drugs are delivered directly into the tumor
Embolic particles are used to block blood flow and trap the drugs
Why Choose TACE Therapy in Germany
Germany is internationally recognized for TACE therapy success. At the University Hospital Frankfurt, Prof. Dr. Thomas J. Vogl is a global expert in this treatment. International patients from the USA, Canada, Australia, and the UK arrange appointments via TIG (Treatment in Germany) for complete support and other logistic arrangements.
Cost of TACE Therapy in Germany
The cost of TACE therapy in Germany ranges between €8,000 and €9,000 per session, including hospitalization, medications, imaging, follow-up care and other logistic arrangements.
TACP Treatment for Small Cell Carcinoma in Germany
What is TACP Treatment?
TACP treatment (Transarterial Chemoperfusion) in Germany is an advanced method where high-dose chemotherapy is delivered directly into the arteries feeding the tumor without embolization. Continuous blood flow reduces the risk of complications.
How TACP Treatment Works in Germany
A catheter is inserted into the femoral artery
High-dose chemotherapy drugs are infused into the arteries supplying the tumor
Continuous blood flow increases drug effectiveness
Why Choose TACP Treatment in Germany
Germany is globally known for TACP treatment provided at advanced oncology centers. Prof. Dr. Thomas J. Vogl, Director of Radiology at the University Hospital Frankfurt, leads this therapy. International patients receive full support from TIG (treatment in Germany) for appointments and treatment planning.
Cost of TACP Treatment in Germany
The cost of TACP treatment in Germany typically ranges between €8,000 and €9,000 per session, which includes the procedure, hospital stay, medications, and follow-up imaging.
Dendritic Cell Therapy for Small Cell Carcinoma in Germany
What is Dendritic Cell Therapy?
Dendritic cell therapy for small cell carcinoma in Germany is a personalized immunotherapy that uses the patient’s immune cells to create a cancer vaccine. The therapy enhances the immune system’s ability to recognize and destroy cancer cells.
How Dendritic Cell Therapy Works in Germany
Blood samples are collected to extract immune cells
At LDG Laboratories Dr. Gansauge Berg, immune cells are transformed into dendritic cells
These cells are trained to recognize tumor antigens
The prepared vaccine is re-infused to trigger an immune response
Why Choose Dendritic Cell Therapy in Germany
Prof. Dr. Frank Gansauge, head of LDG Laboratories, is a pioneer in dendritic cell therapy in Germany. International patients from the USA, Canada, Australia, and the UK choose Germany for strict EU safety standards, advanced laboratory facilities, and tailored treatment programs.
Prof. Dr. Frank Gansauge has authored over a hundred scientific publications in renowned medical and research journals.
Cost of Dendritic Cell Therapy in Germany
The cost of dendritic cell therapy in Germany ranges between €23,000 and €24,000, including diagnostics, vaccine preparation, treatment sessions, and follow-up care.
Comparison of Innovative Small Cell Carcinoma Treatments in Germany
|
Treatment Option |
How It Works |
Specialist |
Success Rate |
Cost in Germany |
|
TACE Therapy |
Delivers chemotherapy directly into tumor arteries and blocks blood supply |
Prof. Dr. Thomas J. Vogl – Radiologist, Frankfurt |
Tumor control, improved response |
€8,000 – €9,000 per session |
|
TACP Treatment |
Infuses high-dose chemotherapy without embolization, preserving blood flow |
Prof. Dr. Thomas J. Vogl – Radiologist, Frankfurt |
Tumor reduction, symptom relief |
€8,000 – €9,000 per session |
|
Dendritic Cell Therapy (Cancer Vaccine) |
Creates a personalized immune vaccine using patient’s cells |
Prof. Dr. Frank Gansauge – LDG Laboratories Berg |
Stronger immune response, improved control |
€23,000 – €24,000 per program |
🌍Why Patients Worldwide Prefer Our Medical Services in Germany – Key Benefits Explained:
Frequently Asked Questions
How long does a person live with small cell carcinoma?
Life expectancy depends on tumor stage, size, and treatment response. Access to the German healthcare system and innovative small cell carcinoma treatments in Germany improves outcomes for international patients, including those from the USA, UK, Canada, and Australia.
Is small cell carcinoma curable?
There is no guaranteed cure, but TACE therapy, TACP treatment, and dendritic cell therapy in Germany aim to slow disease progression, stabilize tumors, and improve quality of life for patients.
Is small cell carcinoma genetic?
Some cases are linked to inherited genetic mutations, but most develop without a family history. German specialists offer genetic testing and personalized treatment plans for international patients.
Will small cell carcinoma show up in blood tests?
No, small cell carcinoma usually does not appear in standard blood tests. Diagnosis requires CT scans, MRI scans, PET scans, and biopsy confirmation.
Who are the best specialists for small cell carcinoma in Germany?
Prof. Dr. Thomas J. Vogl in Germany is a leading specialist in TACE therapy and TACP treatment. Prof. Dr. Frank Gansauge at LDG Laboratories Dr. Gansauge Berg specializes in dendritic cell therapy.
How can international patients get treatment in Germany?
International patients from the USA, UK, Canada, and Australia can contact TIG (Treatment in Germany) for full assistance, including consultation scheduling, treatment planning, medical visa support (if required), travel arrangements, and direct access to German oncology specialists.
To arrange an appointment with top small cell carcinoma specialists in Germany, contact TIG at www.treatmentingermany.com for complete support.
Kindly complete the form below, and our dedicated team will reach out to you promptly. We look forward to connecting with you soon!
Trierer Straße, 56072 Koblenz, Germany
